Clinical trial
Extending and Banding the Roux-en-Y Gastric Bypass
Active, not recruiting · Not applicable · 1 countries · Registry ID NCT05357807
Active, not recruitingNot applicableInterventional
What this study is about
The Roux-en-Y gastric bypass (RYGB) has proven to be an effective treatment for morbid obesity by reducing weight and comorbidities. Extending the pouch may improve weightloss without the increase of complications. Some patients regain weight after initially good weightloss. Placing a minimizer around the pouch may prevent weight regain.
A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.
Basic eligibility
Age18 Years to 65 Years
SexAll
Healthy volunteersNot accepted
ConditionMorbid Obesity
Full registry criteria
Inclusion Criteria: * All patients who are eligible for a primary RYGB Exclusion Criteria: * Bariatric surgery in medical history * Patients with a language barrier which may affect the compliance with medical advice * Patients with a disease not related to morbid obesity, such as Cushing or drug related. * Chronic bowel disease for example Crohn's disease or colitis Colitis. * Renal impairment (MDRD \<30) * Hepatic dysfunction (liver function twice the normal values) * Pregnancy during follow-up * Patients with treatment-resistant reflux symptoms.
Treatments and study arms
Standard RYGB
Procedure
Roux-en-Y Gastric bypass
Extended Pouch RYGB
Procedure
Roux-en-Y gastric bypass with an extended pouch
Banded extended pouch RYGB
Procedure
Roux-en-Y gastric bypass with a banded extended pouch
Primary outcomes
Percentage Total Body Weight Loss (%TBWL)3 years
((preoperative weight - current weight) / (preoperative weight)) x 100%. Weight loss measured in kilograms